🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Ladenburg Thalmann sets price target, buy rating on Legacy Reserves stock

EditorNatashya Angelica
Published 22/10/2024, 15:22
LGCYQ
-

On Tuesday, Legacy Reserves, a for-profit post-secondary education provider, received a new Buy rating from Ladenburg Thalmann. The firm set a stock price target of $8.20 for the company's shares. The new coverage comes as Legacy Reserves continues to expand its educational offerings through strategic acquisitions.

Legacy Reserves, established in 2009, has been actively growing its portfolio of educational institutions. The company's expansion strategy included the acquisition of High Desert Medical College (HDMC), Central Coast College (CCC), and Integrity College of Health (ICH). These institutions have enabled Legacy to diversify its program offerings, focusing on healthcare, medical technology, and business programs.

The analyst from Ladenburg Thalmann highlighted Legacy Reserves' ability to align its career-oriented programs with the labor market demands as a key strength. This alignment is seen as a driving factor behind the company's growth and its potential for future success in the for-profit education sector.

The $8.20 stock price target suggests confidence in Legacy Reserves' growth trajectory and its strategic acquisitions. The rating indicates that the firm believes the stock has a positive outlook and may offer a good opportunity for investors.

Legacy Reserves' focus on healthcare and medical technology is particularly notable, as these sectors continue to experience growth and demand for skilled professionals. By offering programs that cater to these fields, Legacy aims to position its graduates for success in the job market.

In other recent news, Legacy Education Inc. has set the price of its initial public offering (IPO) at $4 per share, planning to offer 2.5 million shares. This move aims to raise $10 million before underwriting discounts and offering expenses. The IPO includes a 30-day option for underwriters, led by Northland Securities, Inc. and Ladenburg Thalmann, to purchase up to an additional 375,000 shares to cover over-allotments.

This recent development follows the company's plan to use the net proceeds from the IPO to invest in its facilities, develop new programs, and for other general working capital purposes. The offering is scheduled to close soon, contingent upon customary closing conditions.

Legacy Education, established in 2009, has expressed its commitment to providing accessible and affordable high-quality education, focusing on organic enrollment growth, new program additions, and strategic acquisitions. These are the latest developments in the company's recent news.

InvestingPro Insights

Legacy Reserves (NYSE:LGCY) has been demonstrating strong financial performance, aligning with the positive outlook presented by Ladenburg Thalmann. According to InvestingPro data, the company's revenue growth stands at an impressive 29.74% over the last twelve months, with quarterly revenue growth in Q4 2024 reaching 34.1%. This robust growth supports the company's expansion strategy through acquisitions and its focus on in-demand educational programs.

InvestingPro Tips highlight that Legacy Reserves is trading at a low P/E ratio relative to its near-term earnings growth, with a PEG ratio of just 0.16. This suggests that the stock may be undervalued considering its growth prospects. Additionally, the company holds more cash than debt on its balance sheet, indicating financial stability as it continues its expansion efforts.

The stock has shown a strong return of 46.52% over the last month, reflecting investor confidence in Legacy Reserves' business model and growth strategy. However, it's worth noting that the RSI suggests the stock may be in overbought territory, which investors should consider when evaluating their positions.

For readers interested in a deeper analysis, InvestingPro offers 5 additional tips for Legacy Reserves, providing a more comprehensive view of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.